Sentences with phrase «growth than pharmaceuticals»

The Salford team recently showed Vitamin C to be up to ten times more effective at stopping cancer cell growth than pharmaceuticals such as 2 - DG, but they say that when Vitamin C is combined with an antibiotic, it is up to ten times more effective, making it nearly 100 times more effective than 2 - DG.

Vitamin C is up to ten times more effective at stopping cancer cell growth than pharmaceuticals such as 2 - DG, according to scientists in Salford, UK.

Not exact matches

The other major problem that Johnson & Johnson faces is that although its pharmaceutical segment has continued to pull more than its fair share of the load of helping the conglomerate stay in growth mode, other businesses have fallen off.

«AbbVie's Baa1 rating reflects the blockbuster success of Humira and the product's good growth outlook, offset by higher leverage and greater product concentration risk than pharmaceutical peers,» says Michael Levesque, analyst at Moody's Investors Service.

That's less than biotechnology (at $ 365 billion) and pharmaceuticals (at $ 1094 billion), but it's a big industry — according to a report by the consulting firm Frost & Sullivan, it's projected to grow over the next 3 to 5 years at an annual rate of 9 %, a growth rate comparable to big pharma.

But it is the first to find that the growth of the pharmaceutical industry itself may be associated with worse rather than better health,» said Hui Zheng, lead author of the study and associate professor of sociology at The Ohio State University.

I scour more than 200 advisories and research reports to select the top recommendations including growth stocks, value stocks, technology, small - caps, biotech, pharmaceuticals, funds, ETFs and more.

For example, if ABC and XYZ are both pharmaceutical companies and an individual believes that ABC will have stronger growth than XYZ between now and June, he could buy June ABC futures contracts and sell June XYZ futures contracts.

Previous to the start - up company experience, I participated broadly, actively and passionately in growth of a dynamic, leading global pharmaceutical, biologic and medical device company from a US entity with 500 employees and $ 100 million in revenue to a state of 60 global affiliates, more than 12,000 employees and revenue of of $ 7 billion.